PharmExec Blog
Follow Us
RSS
Bookstore
Category Archives: Agency Insight
Mining Data to Gain a Competitive Edge
When gauging influence in oncology prescribing, membership in the “club” still counts
As the cancer therapeutics space grows more crowded, the task of identifying and building productive relationships with “key influencers” has become vital to a successful launch strategy. Like everything else in oncology, performing that task is harder today. What was once an inbred club [...]
Biosimilars Spend to Reach $2.5 Bln by 2015: IMS
Global spending on biosimilars is expected to reach between $2 and $2.5 billion by 2015, up from $311 million in 2010, according to an IMS forecast. Total spend on biologics is expected to climb as high as $200 billion.
On a call with reporters yesterday, Murray Aitken, executive director of the IMS Institute for Healthcare Informatics, [...]
Also posted in Biotech, Emerging Markets, Europe, Strategy Tagged biosimilars, forecast, IMS Health 2 Comments
Workforce Shortage in Oncology Imminent
Supply and demand for oncology specialists is expected to become even more unbalanced in the US market over the next 10 years, particularly as the new health reform legislation creates more uncertainty for the reimbursement of the high cost biologic treatments now coming on stream. Several survey are documenting the shortage and suggesting that the [...]
Doing More With Less: A Leadership Perspective